Role of angiostatins in diabetic complications

Tykhomyrov A.A.1, Shram S.I.2 , Grinenko T.V.1

1. Palladin Institute of Biochemistry of the National Academy of Sciences of Ukraine, Kiev, Ukraine
2. Institute of Molecular Genetics, Russian Academy of Sciences, Moscow, Russia
Section: Review
DOI: 10.18097/PBMC20156101041      PubMed Id: 25762598
Year: 2015  Volume: 61  Issue: 1  Pages: 41-56
Angiogenesis is a process through which new blood vessels form from pre-existing vessels. Angiogenesis is regulated by a number of factors of peptide nature. Disbalance of angiogenic system appears to be the major causative factor contributing vascular abnormalities in diabetes mellitus, resulting in various complications. Angiostatins, which are kringle-containing fragments of plasminogen/plasmin, are known to be powerful physiological inhibitors of neovascularization. In the present review, current literature data on peculiarities of production of angiostatins and their functioning at diabetes mellitus are summarized and analyzed for the first time. Also, role of angiostatins in the pathogenesis of typical diabetic complications, including retinopathies, nephropathies and cardiovascular diseases, is discussed. Data presented in this review may be useful for elaboration of novel effective approaches for diagnostics and therapy of vascular abnormalities in diabetes mellitus.
Download PDF:  
Keywords: angiostatins, kringle domains, plasminogen, diabetes mellitus, vascular abnormalities

Tykhomyrov, A. A., Shram, S. I., Grinenko, T. V. (2015). Role of angiostatins in diabetic complications. Biomeditsinskaya Khimiya, 61(1), 41-56.
This paper is also available as the English translation: 10.1134/S1990750814020140
 2024 (vol 70)
 2023 (vol 69)
 2022 (vol 68)
 2021 (vol 67)
 2020 (vol 66)
 2019 (vol 65)
 2018 (vol 64)
 2017 (vol 63)
 2016 (vol 62)
 2015 (vol 61)
 2014 (vol 60)
 2013 (vol 59)
 2012 (vol 58)
 2011 (vol 57)
 2010 (vol 56)
 2009 (vol 55)
 2008 (vol 54)
 2007 (vol 53)
 2006 (vol 52)
 2005 (vol 51)
 2004 (vol 50)
 2003 (vol 49)